Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.56 USD | +2.51% | -1.27% | +16.94% |
Financials (USD)
Sales 2024 * | 25.55M | Sales 2025 * | 70.34M | Capitalization | 363M |
---|---|---|---|---|---|
Net income 2024 * | -71M | Net income 2025 * | -46M | EV / Sales 2024 * | 14.2 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 5.16 x |
P/E ratio 2024 * |
-6.07
x | P/E ratio 2025 * |
-9.68
x | Employees | 100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 44.08% |
Latest transcript on Verrica Pharmaceuticals Inc.
1 day | +2.51% | ||
1 week | -1.27% | ||
Current month | +22.90% | ||
1 month | +24.60% | ||
3 months | +58.52% | ||
6 months | +126.46% | ||
Current year | +16.94% |
Managers | Title | Age | Since |
---|---|---|---|
Ted White
CEO | Chief Executive Officer | 59 | 17-11-30 |
Terence Kohler
DFI | Director of Finance/CFO | 46 | 21-07-15 |
Compliance Officer | 60 | 18-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Prygocki
BRD | Director/Board Member | 58 | 18-04-30 |
Paul Manning
CHM | Chairman | 68 | 15-11-30 |
Craig Ballaron
BRD | Director/Board Member | 63 | 19-06-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +4.20% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 8.56 | +2.51% | 63,105 |
24-05-23 | 8.35 | -7.73% | 248,251 |
24-05-22 | 9.05 | +3.19% | 141,985 |
24-05-21 | 8.77 | +0.80% | 106,519 |
24-05-20 | 8.7 | +0.35% | 326,138 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.94% | 363M | |
+38.51% | 727B | |
+32.46% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.13% | 205B | |
-5.73% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- VRCA Stock